Back to Results
First PageMeta Content
Immunosuppressants / Autoimmune diseases / Monoclonal antibodies / Arthritis / Rheumatology / TNF inhibitor / Etanercept / Infliximab / Rheumatoid arthritis / Medicine / Health / Pharmacology


Rheumatoid Arthritis and the Role of Tumor Necrosis Factor Inhibitors: Clinical Aspects NIH Recombinant DNA Advisory Committee September 17, 2007
Add to Reading List

Document Date: 2013-12-10 14:01:04


Open Document

File Size: 29,29 KB

Share Result on Facebook

Facility

Medicine Mayo Clinic College of Medicine Rochester / /

MedicalCondition

atypical mycobacterial infections / aspergillosis legionellosis / Demyelinating disease / TB / invasive and endemic fungal disease / opportunistic infections / TNF-alpha polymorphisms Opportunistic Infections / disease / severe and active disease / leukopenia / salmonellosis / Rheumatoid Arthritis / Crohn’s disease / histoplasmosis / thrombocytopenia / Herpes / granulomatous infections / Hepatitis B / Rheumatoid arthritis Psoriatic arthritis Ankylosing spondylitis Inflammatory / parasitic disease / dyspnea / interstitial pneumonitis / fever / Beenhower D. Granulomatous infections / tumor necrosis / coccidioidomycosis / Psoriasis / Hypersensitivity / disease modifying anti-rheumatic drugs / Infection RA / infection / inflammatory disease / simplex virus infection / SLE / bowel disease / cough / Infections / /

Organization

Clinical Aspects NIH Recombinant DNA Advisory Committee / Division of Rheumatology / Medicine Mayo Clinic College of Medicine Rochester / /

Person

Eric L. Matteson / /

Position

MPH Chair / /

Product

leflunomide / sulfasalazine / azathioprine / /

Technology

alpha / Recombinant DNA / CVD / /

SocialTag